TABLE 9.
Equilibrium dissociation constants in micromolar for AMPA receptor competitive antagonists
For all antagonist tables, Ki is the equilibrium dissociation constant calculated from radioligand binding studies, and KB is the equilibrium dissociation constant calculated from functional assays using either a Schild analysis or a Cheng-Prusoff correction of IC50 values. IC50 values are the concentration of drug required to produce half-maximal inhibition. Data for CNQX and NBQX inhibition of GluA1 or GluA4 coexpressed with GluA2 can be found in Stein et al. (1992).
Antagonist | GluA1 | GluA2 | GluA3 | GluA4 |
---|---|---|---|---|
μM | ||||
CNQX | 0.6a | 0.18b | 2.11c | |
DNQX | 0.25d | 0.45b | 1.66c | 0.19–0.49d |
NBQX | 0.4e | 0.59f | 0.31–0.63c,f | 0.1e |
ATPO | 38f | 65f | 110f | 150f |
YM90K | 1.96c | |||
NS102 | N.E.c | |||
NS1209 | 0.12g | 0.13g | 0.11g | 0.06g |
Kynurenic acid | 1900h | |||
LY293558 | 9.2i | 0.4–3.2i,j | 32k | 51i |
LY377770 | >100j | |||
LY382884 | N.E.l | N.E.j,l | N.E.l | N.E.l |
LY466195 | 75m | 270m N.E.j | 312m | 432m |
UBP296 | N.E.n | |||
UBP310 | >100o | |||
ACET | >100o |
ACET, (S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione; LY377770, (3S,4aR,6S,8aR)-6-(((1H- tetrazol-5-ylmethyl)oxy)methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid; N.E., no effect; NS102, 5-nitro-6,7,8,9-tetrahydrobenzo[g]indole-2,3-dione-3-oxime; UBP296, (R,S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxybenzyl)pyrimidine-2,4-dione; YM90K, 6-(1H-imidazol-1-yl)-7-nitro-2,3-(1H,4H)-quinoxalinedione.
KB values are from Schild analysis of responses from rat receptors expressed in X. laevis oocytes and activated by kainate (Dawson et al., 1990).
Ki values are for displacing [3H]AMPA binding to BHK cells transfected with GluA2(Q) (Tygesen et al., 1995).
KB values are from the Cheng-Prusoff correction of IC50 values for inhibition of Ca2+ influx evoked by 30 μM glutamate in HEK293 cells transfected with human GluA3 (Varney et al., 1998).
Ki values are for displacing [3H]AMPA binding to BHK cells transfected with rat cDNA (Andersen et al., 1996).
KB values are from Schild analysis of responses from recombinant receptors expressed in X. laevis oocytes activated by glutamate (Stein et al., 1992).
KB values are from the Cheng-Prusoff correction of IC50 values for inhibition of glutamate-activated Ca2+ influx in HEK293 cells stably transfected with rat recombinant receptors (Strange et al., 2006).
Data for GluA1 and GluA4 are Ki values for displacement of [3H]AMPA from Sf9 cells. GluA4 exhibited low- and high-affinity binding; the high-affinity Ki is reported here. Data for GluA2 and GluA3 are KB values from the Cheng-Prusoff correction of IC50 values for inhibition of Ca2+ influx stimulated by glutamate (250 μM) in HEK293 cells stably expressing GluA2 or GluA3 (Kasper et al., 2006).
IC50 values are for inhibition of GluA2 expressed in X. laevis oocytes and activated by 100 μM glutamate (Prescott et al., 2006).
Ki values are for displacing [3H]AMPA at human receptors expressed in HEK293 cells (Simmons et al., 1998).
KB values are from the Cheng-Prusoff correction of IC50 values from inhibition of glutamate (200 μM)-evoked Ca2+ influx at HEK293 cells expressing GluA2. LY377770 caused a 35% inhibition at 100 μM, whereas LY382884 and LY466195 (called compound 5 in this reference) had no effect at 100 μM (Jones et al., 2006).
Ki values are for displacing [3H]AMPA at human GluA3 expressed in HEK293 cells (Bleakman et al., 1999).
Ki values are for displacing [3H]AMPA at human receptors expressed in HEK293 cells. N.E. indicates LY382884 displaced less than 30% at 100 μM (Bortolotto et al., 1999).
Ki values are for displacing [3H]AMPA at human receptors expressed in HEK293 cells (Weiss et al., 2006).
KB values are from the Cheng-Prusoff corrected IC50 values for inhibition of Ca2+ influx evoked by glutamate (100 μM) at human receptors expressed in HEK293 cells (Dolman et al., 2005).
IC50 values are for inhibition of Ca2+ influx activated by 100 μM glutamate at HEK293 cells expressing human GluA2 (Dolman et al., 2007).